Clinical Trial Search

Primary: Lumbar Spine Bone Mineral Density Percent Change From Baseline at Month 24 — -1; 5.6 Percent Change from Baseline — p=<0.0001

Primary: Trough FEV1 Response After 4 Weeks — -0.014; 0.046; 0.082; 0.109 Liter — p=0.0233

Primary: Change in Clinical Activity Score (CAS) — -1.2; -1.5 units on a scale — p=0.73

Primary: Percentage of Participants That Selected a Particular Type of Hearing Aid — 15; 38; 47 percentage of participants

Primary: Number of Participants With a 3-step or Greater Increase in Early Treatment of Diabetic Retinopathy Study (EDTRS) Severity Scale — 127; 124 Participants — p=0.8487

Primary: Target Area Hair Count — 152.7; 158.6; 162.2; 175.7 hairs per centimeter squared — p=<0.0001

Primary: Anxiety Disorders Interview Schedule for Diagnostic and Statistical Manual for Psychological Disorders-IV, Child and Parent Versions (C/P-ADIS) — 19; 3 participants with…

Primary: Angina Class Variation — -2.0; -1.0; -0.5; 4.0 Angina Classification — p=< 0.001

Primary: Percent Drinking Days (%DD) — 19.5; 39.7 percent days in a week — p=0.019

Primary: Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 14 — -1.20; -0.37 Score on a scale — p=<0.0001

Primary: Average Number of Pain Attacks — 3.3533; 3.1807 Pain attacks

Primary: Number of Participants With Tumor Infiltrating Lymphocytes (TIL) Growth — 19; 14; 14; 13 participants

Primary: Muscle Protein Synthesis — 1.38; 0.84; 1.42; 1.36 %/d

Primary: Disease Free Survival — 47; 23; 16 percentage of participants

Primary: Number of Participants in Remission (Per Structured Clinical Interview for DSM-IV Axis I Disorders (SCID)) — 21; 20 participants